FIELD: biotechnology.
SUBSTANCE: invention relates to the field of biotechnology, specifically to a library of vectors containing human HC-CDR3 regions of various lengths, where the diversity of this library is focused by the HC-CDR3 region.
EFFECT: resulting library is optimized in such a way that redundancy is reduced for short HC-CDR3 loops, and the overlap of HC-CDR3 region variants for large loop lengths is increased, which allows the resulting library to be used for effective selection of recombinant antibodies against target antigens.
10 cl, 5 tbl, 11 ex, 15 dwg
Title | Year | Author | Number |
---|---|---|---|
ANTI-PRE-S1 HBV ANTIBODIES | 2016 |
|
RU2739955C2 |
USE OF ANTIBODIES TO SCLEROSTIN FOR TREATING OSTEOGENESIS IMPERFECTA | 2017 |
|
RU2789033C2 |
COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING INFECTIONS CAUSED BY STAPHYLOCOCCUS AUREUS | 2015 |
|
RU2764981C1 |
MODIFIED IGG ANTIBODIES WHICH BIND TO A TRANSFORMING GROWTH FACTOR BETA-1 WITH HIGH AFFINITY, AVIDITY AND SPECIFICITY | 2016 |
|
RU2728858C2 |
ANTIBODIES SPECIFIC TO FLT3 AND THEIR APPLICATIONS | 2018 |
|
RU2758513C2 |
ANTIBODIES TO TICAGRELOR AND APPLICATION METHODS | 2015 |
|
RU2754468C2 |
DOSING REGIMEN OF A WNT INHIBITOR AND AN ANTI-PD-1 ANTIBODY MOLECULE IN A COMBINATION | 2018 |
|
RU2767533C2 |
ANTIBODIES TO PD-1 AND THEIR APPLICATION | 2017 |
|
RU2761640C2 |
ANTIBODIES BINDING CD3 | 2017 |
|
RU2779489C2 |
PROCOAGULANT ANTIBODIES | 2018 |
|
RU2810094C2 |
Authors
Dates
2021-03-25—Published
2017-09-06—Filed